Factor V Leiden is one of those Step 1 “easy points” topics that can turn into a trap if you don’t know exactly what’s mutated, what lab tests do (and don’t) change, and when it actually matters clinically. This post is your deep, high-yield walkthrough—from mechanism to management—so you can recognize it instantly in vignettes and avoid common pitfalls.
Where Factor V Leiden Fits in Hemostasis (Big Picture)
Normal clotting is a balance:
- Pro-coagulant side: thrombin generation → fibrin clot
- Anti-coagulant side: checks and balances (especially Protein C + Protein S degrading Factors Va and VIIIa)
Factor V Leiden (FVL) is the classic inherited cause of hypercoagulability due to resistance to Protein C.
Step 1 framing: FVL = “APC resistance” → too much Factor Va activity → more thrombin → venous clots.
Definition (What It Is)
Factor V Leiden is an inherited point mutation in Factor V that makes it resistant to inactivation by activated Protein C (APC).
- Inheritance: autosomal dominant (with variable penetrance)
- Most common inherited thrombophilia in people of European ancestry
- Often discovered after a DVT/PE, especially if “unprovoked” or at a young age
Pathophysiology (What’s Mutated + Why It Clots)
The normal brake: Protein C system
- Thrombin bound to thrombomodulin activates Protein C
- Activated Protein C (APC) + Protein S → degrade Factor Va and Factor VIIIa
- Result: reduced thrombin generation (anti-coagulant effect)
The mutation
Factor V Leiden is classically a single amino acid substitution (high-yield detail: Arginine → Glutamine at a key cleavage site, often cited as Arg506Gln). This eliminates an APC cleavage site.
The consequence
- Factor Va cannot be “turned off” efficiently
- Persistent Factor Va → more conversion of prothrombin (II) to thrombin (IIa)
- More thrombin → more fibrin → hypercoagulability
Clinical Presentation (How It Shows Up)
Typical “board-style” presentations
Venous thromboembolism (VTE):
- Deep vein thrombosis (DVT): unilateral leg swelling, pain, warmth
- Pulmonary embolism (PE): dyspnea, pleuritic chest pain, tachycardia
High-yield pattern
- Venous clots >> arterial clots
(Arterial thrombosis is more about platelets + endothelial injury: think atherosclerosis, smoking, etc.)
Risk modifiers (when it becomes clinically loud)
Factor V Leiden often needs a “push”:
- Pregnancy / postpartum
- Oral contraceptives / estrogen therapy
- Surgery/immobility
- Malignancy
- Prior VTE history
Heterozygous vs homozygous (testable)
- Heterozygous: increased VTE risk (clinically common)
- Homozygous: much higher VTE risk; may present earlier and recur more
What it usually does not cause (common distractors)
- Mucocutaneous bleeding (that’s platelet problems/vWF)
- Hemarthroses (hemophilia A/B)
- Isolated arterial thrombosis (not classic)
- Abnormal PT/PTT at baseline (typically normal)
Diagnosis (How They Test It)
Initial labs (often normal)
- PT: usually normal
- aPTT: usually normal
- Bleeding time: normal
So if a vignette gives you normal PT/aPTT but recurrent DVTs—think inherited thrombophilia.
Specific testing options
1) Functional assay: APC resistance test (high-yield concept)
- Add APC and see if clotting time appropriately prolongs.
- In FVL: blunted/absent prolongation → “APC resistance”
Many questions phrase this as: “Factor V resistant to inactivation by Protein C.”
2) Genetic testing (confirmatory)
- PCR/DNA testing for the Factor V Leiden mutation
Important diagnostic pitfall (Step-style)
If the question is really about Protein C or Protein S deficiency, expect:
- Risk of thrombosis
- Often a story of warfarin-induced skin necrosis (especially with Protein C deficiency)
Factor V Leiden does not classically cause warfarin skin necrosis as a signature association.
Treatment & Management (What You Actually Do)
Acute VTE (same as other causes)
Treat DVT/PE according to standard protocols:
- Anticoagulation (commonly a DOAC like apixaban/rivaroxaban, or heparin → warfarin depending on scenario)
- Duration depends on whether the clot was provoked vs unprovoked and recurrence risk
Long-term anticoagulation?
Not everyone with Factor V Leiden needs lifelong anticoagulation.
Consider extended anticoagulation if:
- Recurrent VTE
- Unprovoked VTE
- High-risk thrombophilia state (e.g., homozygous FVL, strong family history, combined thrombophilias)
Pregnancy considerations (high-yield)
- Pregnancy is hypercoagulable even without FVL.
- If history of VTE and FVL: prophylaxis may be indicated (often LMWH).
- Warfarin is teratogenic (classic Step fact); LMWH is commonly used in pregnancy.
Prevention counseling points (vignette-friendly)
- Avoid or carefully weigh estrogen-containing OCPs if prior VTE or strong thrombophilia history
- Prophylaxis for high-risk periods (major surgery, prolonged immobility) as clinically indicated
High-Yield Associations & “Classic USMLE Lines”
What Step writers love to say
- “Activated Protein C resistance”
- “Recurrent DVTs in a young patient”
- “Family history of venous thromboembolism”
- “Hypercoagulable workup otherwise normal”
- “Clots after starting OCPs” or during pregnancy
What they like to contrast it with
| Condition | Key defect | PT/aPTT? | Classic association |
|---|---|---|---|
| Factor V Leiden | Factor V resistant to APC | Normal | Recurrent venous thrombosis |
| Protein C deficiency | ↓ inactivation of Va/VIIIa | Normal | Warfarin skin necrosis, neonatal purpura fulminans |
| Protein S deficiency | Same pathway (cofactor for APC) | Normal | VTE, can mimic Protein C deficiency |
| Antiphospholipid syndrome | Autoantibodies (lupus anticoagulant, anticardiolipin, anti-β2GP1) | ↑ aPTT but thrombosis | Thrombosis + pregnancy morbidity; false + VDRL/RPR |
| Prothrombin G20210A | ↑ prothrombin levels | Normal | VTE |
| ATIII deficiency | ↓ inhibition of thrombin/Xa | Normal | Heparin resistance, VTE |
First Aid Cross-References (How to Find It Fast)
In First Aid for the USMLE Step 1, Factor V Leiden is typically covered in the Hematology section under:
- Hypercoagulable states / thrombophilias
- Often near Protein C/S deficiency, Antithrombin deficiency, and Prothrombin mutation
- Look for the phrase: “resistant to activated protein C”
Use this as your mental “FA anchor”:
- Factor V Leiden = APC resistance = venous thrombosis
- Everything else is mostly normal on routine coag labs.
Rapid-Fire Step 1 Must-Knows (Final Review)
- Most common inherited thrombophilia (especially in European ancestry)
- AD mutation in Factor V → resistant to APC
- Causes venous thromboembolism (DVT/PE), not a primary bleeding disorder
- PT/aPTT usually normal
- Risk increases with estrogen, pregnancy, immobility, surgery
- Diagnose via APC resistance assay and/or genetic testing
- Treat actual clots with standard anticoagulation; prophylaxis based on risk context